InsidersTradesSigma
Explore the detailed record of transactions filed by 정현호, Dirigeant. Director active across 2 companies, notably 메디톡스. In total, 4 reports have been published. The latest transaction was filed on 3 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
4 of 4 declarations
Jung Hyun-ho is an executive at Meditox, a company specializing in the development of biopharmaceutical products. He is involved in the management and strategic direction of the company, contributing to its development and innovation. His vision and leadership are essential for Meditox's growth in the biopharmaceutical market.